Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
The price of Arcus Biosciences Inc (NYSE: RCUS) closed at $17.47 in the last session, up 1.04% from day before closing price of $17.29. In other words, the price has increased by $1.04 from its previous closing price. On the day, 0.5 million shares were traded. RCUS stock price reached its highest trading level at $17.96 during the session, while it also had its lowest trading level at $17.2531.
Ratios:
We take a closer look at RCUS’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 5.23 and its Current Ratio is at 5.23. In the meantime, Its Debt-to-Equity ratio is 0.10 whereas as Long-Term Debt/Eq ratio is at 0.08.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on October 21, 2024, initiated with a Neutral rating and assigned the stock a target price of $20.
On October 08, 2024, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $29.
On November 18, 2022, BofA Securities started tracking the stock assigning a Neutral rating and target price of $33.BofA Securities initiated its Neutral rating on November 18, 2022, with a $33 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 02 ’24 when Azoy Alexander sold 201 shares for $15.32 per share. The transaction valued at 3,079 led to the insider holds 19,070 shares of the business.
Azoy Alexander sold 1,357 shares of RCUS for $20,314 on Aug 13 ’24. The Chief Accounting Officer now owns 19,070 shares after completing the transaction at $14.97 per share. On Mar 27 ’24, another insider, Jarrett Jennifer, who serves as the Chief Operating Officer of the company, sold 11,551 shares for $17.55 each. As a result, the insider received 202,720 and left with 215,253 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RCUS now has a Market Capitalization of 1598707584 and an Enterprise Value of 588707840. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.14 while its Price-to-Book (P/B) ratio in mrq is 2.83. Its current Enterprise Value per Revenue stands at 2.238 whereas that against EBITDA is -2.044.
Stock Price History:
Over the past 52 weeks, RCUS has reached a high of $20.31, while it has fallen to a 52-week low of $13.52. The 50-Day Moving Average of the stock is 6.48%, while the 200-Day Moving Average is calculated to be 6.81%.
Shares Statistics:
According to the various share statistics, RCUS traded on average about 733.53K shares per day over the past 3-months and 706670 shares per day over the past 10 days. A total of 91.50M shares are outstanding, with a floating share count of 48.11M. Insiders hold about 47.43% of the company’s shares, while institutions hold 54.46% stake in the company. Shares short for RCUS as of 1731628800 were 7570712 with a Short Ratio of 10.32, compared to 1728950400 on 6337902. Therefore, it implies a Short% of Shares Outstanding of 7570712 and a Short% of Float of 17.06.
